These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34669997)

  • 1. FERM domain-containing protein 6 exerts a tumor-inhibiting role in thyroid cancer by antagonizing oncogenic YAP1.
    Wang W; Zhao C; Quan F; Zhang P; Shao Y; Liu L
    Biofactors; 2022 Mar; 48(2):428-441. PubMed ID: 34669997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Ras protein activator like 2 produces antitumor effects in gastric cancer via the suppression of YAP1 activation.
    Hu Y; Zhang P; Shi Y; Dong X; Wu Y; Dong D; Li E; Fan Y
    Environ Toxicol; 2022 Mar; 37(3):527-538. PubMed ID: 34826200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.
    Shi H; Zhang Y; Wang Y; Fang P; Liu Y; Li W
    Toxicol Appl Pharmacol; 2022 Mar; 439():115926. PubMed ID: 35182550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
    Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
    Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FRMD6 has tumor suppressor functions in prostate cancer.
    Haldrup J; Strand SH; Cieza-Borrella C; Jakobsson ME; Riedel M; Norgaard M; Hedensted S; Dagnaes-Hansen F; Ulhoi BP; Eeles R; Borre M; Olsen JV; Thomsen M; Kote-Jarai Z; Sorensen KD
    Oncogene; 2021 Jan; 40(4):763-776. PubMed ID: 33249427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
    Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
    Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.
    Xu Y; Wang K; Yu Q
    Oncotarget; 2016 Oct; 7(43):70080-70091. PubMed ID: 27661120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of zinc finger protein 367 exerts a tumor suppressive role in colorectal cancer by affecting the activation of oncogenic YAP1 signaling.
    Lei T; Gao Y; Duan Y; Cui C; Zhang L; Si M
    Environ Toxicol; 2021 Nov; 36(11):2278-2290. PubMed ID: 34351699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
    Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
    Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc00887 suppresses tumorigenesis of cervical cancer through regulating the miR-454-3p/FRMD6-Hippo axis.
    Li P; Wang J; Zhi L; Cai F
    Cancer Cell Int; 2021 Jan; 21(1):33. PubMed ID: 33413358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
    Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
    Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progression.
    Wang T; Guo H; Zhang L; Yu M; Li Q; Zhang J; Tang Y; Zhang H; Zhan J
    Front Med; 2023 Aug; 17(4):714-728. PubMed ID: 37060526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
    Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
    Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression.
    You MH; Jeon MJ; Kim SR; Lee WK; Cheng SY; Jang G; Kim TY; Kim WB; Shong YK; Kim WG
    Sci Rep; 2021 Jan; 11(1):2054. PubMed ID: 33479369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.
    Lorenzetto E; Brenca M; Boeri M; Verri C; Piccinin E; Gasparini P; Facchinetti F; Rossi S; Salvatore G; Massimino M; Sozzi G; Maestro R; Modena P
    Oncotarget; 2014 May; 5(9):2608-21. PubMed ID: 24810989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
    Cao XZ; Bin H; Zang ZN
    Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.